You are here
Register for the E-Alert
We would like to know what challenges you face in treating patients with advanced breast cancer.
Send us your feedback and take this opportunity to submit your questions to our faculty.
Clinicians have an unmet need to understand the mechanisms underlying CDK4&6 inhibition, the rationale for using CDK4&6 inhibitors to treat advanced breast cancer, and the clinical data supporting the use of CDK4&6 inhibitors in the treatment of advanced breast cancer.